4 курс / Акушерство и гинекология / Бесплодие_Диагностика,_современные_методы_лечения
.pdf83.Paulina A. et al. The Pathophysiology of Miscarriage in Women with Polycystic Ovary Syndrome // Review and Proposed Hypothesis of Mechanisms Involved Hormones. - 2004. - N 3(4). - P. 221-227.
84.Petrikova J., Lazurova I., Yehuda S. Polycystic ovary syndrome and autoimmunity // Eur. J. Intern. Med. 2010. - N 21. - P. 369-371.
85.Lamminpaa R., Vehvilainen-Julkunen K., Gissler M., Heino-nen S. Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 19972008 // BMC Pregnancy Childbirth. - 2012. - N 12. - P. 47. - Published online 2012 Jun 11. - doi: 10.1186/1471-2393-12-47.
86.Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome // Fertil. Steril. - 2004. - N 81. - P. 19-25.
87.Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) // Hum. Reprod. - 2004. - N 19. - P. 41-47.
88.Schindler A.E. Non-contraceptive benefits of oral hormonal contraceptives // Int. J. Endocrinol. Metab. - 2013. - N 11 (1). - P. 41-47.
89.Schramm G.A., Steffens D. A 12-month evaluation of the CMA-containing oral contraceptive Belara: efficacy, tolerability and anti-androgenic properties // Contraception. - 2003. - N 67 (4). - P. 305-312.
90.Speroff L., Fritz M.A. Clinical Gynecologic Endocrinology & Infertility. - 7th еd. - Lippincott Williams & Wilkins, 2005.
91.The Practice Committee of the American Society for Reproductive Medicine Evaluation and Treatment of Recurrent Pregnancy Loss. A Committee Opinion // Fertil Steril. - 2012. - Vol. 98. - Issue 5. - P. 1103-1111.
92.Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome // Fertil. Steril. - 2008. - N 89. - P. 505-522.
93.Tso L.O., Costello M.F., Albuquerque L.E. et al. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome // Cochrane Database Syst Rev. - 2014. - N 11. - CD006105.
94.Tummers P., De Sutter P., Dhont M. Risk of spontaneous abortion in singleton and twin pregnancies after IVF/ ICSI // Human Reproduction. - 2003. - Vol. 18, N
8.- P. 1720-1723.
95.Uras R., Orru M., Pani F. et al. Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome. -
2010. - N 82 (2). - P. 131-138. - http://www.ncbi.nlm.nih.gov/pubmed/20654753Contraception.
96.Wagenaar K., Huisman J., Cohen-Kettenis P.T. An overview of studies on early development, cognition, and psychosocial well-being in children born after in vitro fertilization // J. Dev. Behav. Pediatr. - 2008. - Vol. 29, N 3. - Р. 219-230.
97.Weiss N.S., Nahuis M., Bayram N. et al. conadotrophins for ovulation induction in women with polycystic ovarian syndrome // Cochrane Database Syst Rev. - 2015. -Vol. 9, N 9. - CD010290.
98.Wu C.C., Lei P., Ruan Y.M. et al. Effects of oral contraceptive pretreatment on controlled ovarian hyperstimulation and outcomes of IVF-ET // Zhonghua Nan Ke Xue. - 2012. - N 18 (7). - P. 623-626.
99.Zimmerman Y., Eijkemans M.J.C., Coelingh H.J. et al. The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis // Human Reproduction Update. - 2014. - Vol. 20, N 1. - P. 76-
Рекомендовано к покупке и изучению сайтом МедУнивер - https://meduniver.com/